Drug intelligence / Profile preview

Elemental 028

Development stage: Unknown
Lead developer: Nutricia
Administration: Oral

Overview

Elemental 028 is an amino acid-based nutritional supplement, specifically an elemental feed, designed to provide complete daily amounts of both macronutrients and micronutrients. It is intended for the dietary management of conditions involving severe impairment of the gastrointestinal tract, such as inflammatory bowel disease, short bowel syndrome, intractable malabsorption, allergic disease, and neurodegenerative diseases, where an elemental diet is required. The product is ACBS approved, indicating its acceptance for prescription in the UK.

Brand names: Elemental 028 Extra LiquidElemental028 Extra LiquidElemental-028 Extra LiquidElemental 028 Extra PowderElemental028 Extra PowderElemental-028 Extra Powder
Other names: Elemental 028 ExtraElemental028 ExtraElemental-028 Extra

Beyond the preview

Go deeper on Elemental 028.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elemental 028.

Explore the full profile